| Outcome Measures: |
Primary: Atrial fibrillation (AF), atrial flutter (AFL), or atrial tachycardia events lasting ≥30 seconds occurring from the end of a 3-month blanking period post-procedure up to 12 months of follow-up., at least 12 months of follow-up, beyond the initial 3-month blanking period | Secondary: Changes in Body Mass Index (BMI) from baseline to 12 months., Combine weight and height, and report the Body Mass Index (BMI) in units of kilograms per square meter (kg/m²)., at least 12 months of follow-up, beyond the initial 3 month blanking period|Quality of life assessments., The quality of life and cardiac function of the subjects were assessed using the World Health Organization Quality of Life (WHOQOL-100) questionnaire., at least 12 months of follow-up, beyond the initial 3-month blanking period|Complications associated with AF ablation and serious adverse events (such as rehospitalizations, cardiovascular rehospitalizations) occurring during the study period., at least 12 months of follow-up, beyond the initial 3-month blanking period|Quality of life assessments, Quality of life assessments were conducted within at least 12 months of follow-up using measures such as the AF6., at least 12 months of follow-up, beyond the initial 3-month blanking period|Quality of life assessments, Quality of life assessments were conducted using the AFEQT (Atrial Fibrillation Effect on Quality of Life) questionnaire., at least 12 months of follow-up, beyond the initial 3-month blanking period|Psychological distress, Psychological distress was assessed using the HADS (Hospital Anxiety and Depression Scale)., at least 12 months of follow-up, beyond the initial 3-month blanking period|Functional status, Functional status was assessed using the CCS-SAF (Canadian Cardiovascular Society - Self-Assessed Functioning scale)., at least 12 months of follow-up, beyond the initial 3 month blanking period|quality of life, The quality of life and cardiac function of the subjects were assessed using the New York Heart Association (NYHA) functional classification., at least 12 months of follow-up, beyond the initial 3-month blanking period
|
